SUCLG2 and neoplasm: That is, samples with elevated SUCLG2 levels were predominantly associated with cell cycle checkpoints and protein secretion pathways that were indicative of the potential mechanisms by which SUCLG2 may contribute to tumor aggressiveness (Figure 4B).